1. A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial). Issue 4 (16th December 2017) Authors: Stürner, Klarissa Hanja; Stellmann, Jan-Patrick; Dörr, Jan; Paul, Friedemann; Friede, Tim; Schammler, Sven; Reinhardt, Stefanie; Gellissen, Susanne; Weissflog, Gainet; Faizy, Tobias Djamsched; Werz, Oliver; Fleischer, Sabine; Vaas, Lea A I; Herrmann, Frank; Pless, Ole; Martin, Roland; Heesen, Chr... Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 89:Issue 4(2018) Page Start: 330 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗